Previous animal experiments have demonstrated that Th1 cells have a pro-atherogenic effect, including studies with IFN-γ deficient mice [43,44,45] and mice genetically deficient in the Th1 transcription factor T-bet [46], all of which exhibited reduced atherosclerosis development. The gene discussed is IFNG; the disease is atherosclerosis.